Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 15
2.1 What Is This Report About? 15
2.2 Definitions
15
2.2.1 Wound Care Management 15
3 Healthcare Sector Review 17
3.1 Healthcare Expenditure 17
3.2 Healthcare Infrastructure 20
3.3
Healthcare Policy 24
4 Wound Care Management in Republic of Korea 25
4.1 Wound Care Management Overall Revenues (2000-2012) 25
4.2 Wound Care
Management Overall Volume (2000-2012) 31
4.3 Wound Care Management Overall
Company Shares (2005-2006) 34
5 Wound Closure Devices in Republic of Korea
35
5.1 Wound Closure Devices Overall Revenues (2000-2012) 35
5.1.1
Skin Closure Devices Overall Revenues (2000-2012) 39
5.1.2 Hemostats
Overall Revenues (2000-2012) 41
5.1.3 Tissue Sealants Overall Revenues
(2000-2012) 43
5.2 Wound Closure Devices Overall Volume (2000-2012) 45
5.2.1 Skin Closure Devices Overall Volume (2000-2012) 47
5.2.2 Hemostats
Overall Volume (2000-2012) 49
5.2.3 Tissue Sealants Overall Volume
(2000-2012) 51
5.3 Wound Closure Devices Average Price (2000-2012) 53
5.3.1 Hemostats Average Price (2000-2012) 53
5.3.2 Tissue Sealants Average
Price (2000-2012) 55
5.3.3 Skin Closure Devices Average Price (2000-2012)
57
5.4 Wound Closure Devices Distribution Share (2000-2012) 59
5.5
Wound Closure Devices Company Share (2000-2012) 60
6 Ostomy in Republic of
Korea 61
6.1 Ostomy Overall Revenue (2000-2012) 61
6.2 Ostomy Overall
Volume (2000-2012) 63
6.3 Ostomy Average Price (2000-2012) 65
6.4
Ostomy Distribution Share (2005-2006) 67
6.5 Ostomy Company Share
(2005-2006) 68
7 Advanced Wound Management in Republic of Korea 69
7.1
Advanced Wound Management Overall Revenue (2000-2012) 69
7.2 Advanced
Wound Management Overall Volume (2000-2012) 71
7.3 Advanced Wound
Management Average Price (2000-2012) 73
7.4 Advanced Wound Management
Distribution Share (2005-2006) 75
7.5 Advanced Wound Management Company
Share (2005-2006) 76
8 Traditional Wound Management in Republic of Korea
77
8.1 Traditional Wound Management Overall Revenue (2000-2012) 77
8.2
Traditional Wound Management Overall Volume (2000-2012) 79
8.3 Traditional
Wound Management Average Price (2000-2012) 81
8.4 Traditional Wound
Management Distribution Share (2000-2012) 83
8.5 Traditional Wound
Management Company Share (2000-2012) 84
9 Compression Therapy in Republic
of Korea 85
9.1 Compression Therapy Overall Revenue (2000-2012) 85
9.2
Compression Therapy Category Volume (2000-2012) 87
9.3 Compression Therapy
Average Price (2000-2012) 89
9.4 Compression Therapy Distribution Share
(2000-2012) 91
9.5 Compression Therapy Company Share (2000-2012) 92
10
Covidien Ltd./Tyco Healthcare Company Profile 93
10.1 Company Overview
93
10.2 Business Overview 93
10.2.1 Imaging Solutions 93
10.2.2
Medical Devices 94
10.2.3 Medical Supplies 94
10.2.4 Pharmaceutical
Products 95
10.2.5 Retail Products 95
10.2.6 Products 96
10.2.7
History 97
10.3 Value Chain Analysis 98
10.3.1 Manufacturing 98
10.3.2 Product Development 99
10.3.3 Sales and Marketing 100
10.4 SWOT
Analysis 100
10.4.1 Covidien Ltd./Tyco Healthcare Strengths 101
10.4.2
Covidien Ltd./Tyco Healthcare Weaknesses 101
10.4.3 Covidien Ltd./Tyco
Healthcare Opportunities 102
10.4.4 Covidien Ltd./Tyco Healthcare Threats
103
10.5 Financial and Operational Review 104
10.5.1 Financial
Statements 104
10.5.2 Financial Ratios 105
10.6 Locations And
Subsidiaries 106
10.7 Covidien Ltd./Tyco Healthcare Pipeline Products
108
10.7.1 PleuraSeal Lung Sealant System 108
10.7.2 Sandman Intro
CPAP Device 109
11 3M Company Profile 111
11.1 Company Overview
111
11.2 Business Overview 111
11.2.1 Consumer and Office 111
11.2.2 Display and Graphics 111
11.2.3 Electro and Communications 112
11.2.4 Health Care 113
11.2.5 Industrial and Transportation 113
11.2.6
Safety, Security and Protection Services 114
11.2.7 Products 115
11.3
Value Chain Analysis 117
11.3.1 Manufacturing 117
11.3.2 Product
Development 118
11.3.3 Sales and Marketing 118
11.4 SWOT Analysis
119
11.4.1 3M Company Strengths 119
3M Company Weaknesses 120
3M
Company Opportunities 120
3M Company Threats 121
11.5 Financial and
Operational Review 122
11.6 Locations And Subsidiaries 123
12 Ethicon,
Inc. Company Profile 125
12.1 Company Overview 125
12.2 Business
Overview 125
12.2.1 Products 126
12.3 Locations And Subsidiaries
127
13 Smith & Nephew Plc Company Profile 129
13.1 Company Overview
129
13.2 Business Overview 129
13.2.1 Advanced Wound Management
129
13.2.2 Endoscopy 130
13.2.3 Reconstruction 130
13.2.4 Trauma
and Clinical Therapies 131
13.2.5 Products 132
13.2.6 History 132
13.3 Value Chain Analysis 136
13.3.1 Manufacturing 136
13.3.2 Product
Development 137
13.3.3 Sales and Marketing 138
13.4 SWOT Analysis
138
13.4.1 Smith & Nephew Plc Strengths 138
13.4.2 Smith & Nephew Plc
Weaknesses 139
13.4.3 Smith & Nephew Plc Opportunities 139
13.4.4
Smith & Nephew Plc Threats 140
13.5 Financial and Operational Review
141
13.6 Locations And Subsidiaries 142
13.7 Smith & Nephew Plc
Pipeline Products 144
13.7.1 R3 Modular resurfacing Acetabular system
144
13.7.2 R3 Ceramic-on-ceramic Acetabular System 144
14 The HARTMANN
GROUP Company Profile 145
14.1 Company Overview 145
14.2 Business
Overview 145
14.2.1 Incontinence Management 145
14.2.2 Operating
Theater Management 145
14.2.3 Other GROUP Activities 146
14.2.4 Wound
Management 146
14.2.5 Products 147
14.2.6 History 148
14.3 Value
Chain Analysis 150
14.3.1 Manufacturing 150
14.3.2 Product Development
150
14.3.3 Sales and Marketing 151
14.4 SWOT Analysis 151
14.4.1
HARTMANN GROUP Strengths 151
14.4.2 HARTMANN GROUP Weaknesses 152
14.4.3 HARTMANN GROUP Opportunities 152
14.4.4 HARTMANN GROUP Threats
153
14.5 Financial and Operational Review 155
14.6 Locations And
Subsidiaries 156
15 Regulation System 158
15.1 Medical Equipment
Approval Process 158
15.1.1 Classification 158
15.1.2 Premarket
Notification for Class I Devices 159
15.1.3 Pre-market Approval for Class
II, III and IV Devices 159
15.1.4 License Fee 160
15.1.5 License
Application Processing Duration 160
15.2 Post-market Surveillance 161
16 Pricing and Reimbursement 162
17 Distribution Structure 165
17.1
Distribution Structure 165
18 Appendix 166
18.1 Global Markets Direct
Research Methodology 166
18.2 Coverage 167
18.3 Secondary Research
167
18.4 Primary Research 168
18.5 Models 168
18.6 Forecasts
169
18.7 Expert Panels 169
18.8 Currency Conversion 170
18.9
Contact Us 171
18.10 Disclaimer 171
1.1 List of Tables
Table
1: Hospital Wards by Specialty in Republic of Korea, 2003-2007 21
Table 2:
Doctors by Specialty in Republic of Korea, 2003-2007 22
Table 3:
Healthcare Institutions in Republic of Korea, 2001-2005 23
Table 4:
Healthcare Personnel in Republic of Korea, 1975-2002 23
Table 5: Wound
Care Management, Republic of Korea, Overall Revenues ($ mn), 2000-2012 25
Table 6: Wound Care Management, Republic of Korea, Overall Revenues ($ mn),
Historic, 2000-2007 26
Table 7: Wound Care Management, Republic of Korea,
Overall Revenues ($ mn), Forecast, 2007-2012 27
Table 8: Wound Care
Management, Republic of Korea, Category Revenues ($ mn), 2000-2012 28
Table 9: Wound Care Management, Republic of Korea, Category Revenues ($ mn),
Historic, 2000-2007 29
Table 10: Wound Care Management, Republic of Korea,
Category Revenues ($ mn), Forecast, 2007-2012 30
Table 11: Wound Care
Management, Republic of Korea, Category Volume (Units), 2000-2012 31
Table
12: Wound Care Management, Republic of Korea, Category Volume (Units),
Historic, 2000-2007 32
Table 13: Wound Care Management, Republic of Korea,
Category Volume (Units), Forecast, 2007-2012 33
Table 14: Wound Care
Management, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006
34
Table 15: Wound Closure Devices, Republic of Korea, Overall Revenues ($
mn), Historic, 2000-2007 35
Table 16: Wound Closure Devices, Republic of
Korea, Overall Revenues ($ mn), Forecast, 2007-2012 36
Table 17: Wound
Closure Devices, Republic of Korea, Revenue by Segment ($ mn), Historic,
2000-2007 37
Table 18: Wound Closure Devices, Republic of Korea, Revenue
by Segment ($ mn), Forecast, 2007-2012 38
Table 19: Skin Closure Devices,
Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 39
Table
20: Skin Closure Devices, Republic of Korea, Overall Revenues ($ mn),
Forecast, 2007-2012 40
Table 21: Hemostats, Republic of Korea, Overall
Revenues ($ mn), Historic, 2000-2007 41
Table 22: Hemostats, Republic of
Korea, Overall Revenues ($ mn), Forecast, 2007-2012 42
Table 23: Tissue
Sealants, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007
43
Table 24: Tissue Sealants, Republic of Korea, Overall Revenues ($ mn),
Forecast, 2007-2012 44
Table 25: Wound Closure Devices, Republic of Korea,
Overall Volume (Units), Historic, 2000-2007 45
Table 26: Wound Closure
Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 46
Table 27: Skin Closure Devices, Republic of Korea, Overall Volume (Units),
Historic, 2000-2007 47
Table 28: Skin Closure Devices, Republic of Korea,
Overall Volume (Units), Forecast, 2007-2012 48
Table 29: Hemostats,
Republic of Korea, Overall Volume (Units), Historic, 2000-2007 49
Table
30: Hemostats, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012
50
Table 31: Tissue Sealants, Republic of Korea, Overall Volume (Units),
Historic, 2000-2007 51
Table 32: Tissue Sealants, Republic of Korea,
Overall Volume (Units), Forecast, 2007-2012 52
Table 33: Hemostats,
Republic of Korea, Average Price ($), Historic, 2000-2007 53
Table 34:
Hemostats, Republic of Korea, Average Price ($), Forecast, 2007-2012 54
Table 35: Tissue Sealants, Republic of Korea, Average Price ($), Historic,
2000-2007 55
Table 36: Tissue Sealants, Republic of Korea, Average Price
($), Forecast, 2007-2012 56
Table 37: Skin Closure Devices, Republic of
Korea, Average Price ($), Historic, 2000-2007 57
Table 38: Skin Closure
Devices, Republic of Korea, Average Price ($), Forecast, 2007-2012 58
Table 39: Wound Closure Devices, Republic of Korea, Distribution Share by
Revenue ($ mn), 2005-2006 59
Table 40: Wound Closure Devices, Republic of
Korea, Company Share by Revenue ($ mn), 2005-2006 60
Table 41: Ostomy,
Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 61
Table
42: Ostomy, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012
62
Table 43: Ostomy, Republic of Korea, Overall Volume (Units), Historic,
2000-2007 63
Table 44: Ostomy, Republic of Korea, Overall Volume (Units),
Forecast, 2007-2012 64
Table 45: Ostomy, Republic of Korea, Average Price
($), Historic, 2000-2007 65
Table 46: Ostomy, Republic of Korea, Average
Price ($), Forecast, 2007-2012 66
Table 47: Ostomy, Republic of Korea,
Distribution Share by Revenue ($ mn), 2005-2006 67
Table 48: Ostomy,
Republic of Korea, Company Share by Revenue ($ mn), 2005-2006 68
Table 49:
Advanced Wound Management, Republic of Korea, Overall Revenues ($ mn),
Historic, 2000-2007 69
Table 50: Advanced Wound Management, Republic of
Korea, Overall Revenues ($ mn), Forecast, 2007-2012 70
Table 51: Advanced
Wound Management, Republic of Korea, Overall Volume (Units), Historic,
2000-2007 71
Table 52: Advanced Wound Management, Republic of Korea,
Overall Volume (Units), Forecast, 2007-2012 72
Table 53: Advanced Wound
Management, Republic of Korea, Average Price ($), Historic, 2000-2007 73
Table 54: Advanced Wound Management, Republic of Korea, Average Price ($),
Forecast, 2007-2012 74
Table 55: Advanced Wound Management, Republic of
Korea, Distribution Share by Revenue ($ mn), 2005-2006 75
Table 56:
Advanced Wound Management, Republic of Korea, Company Share by Revenue ($ mn),
2005-2006 76
Table 57: Traditional Wound Management, Republic of Korea,
Overall Revenues ($ mn), Historic, 2000-2007 77
Table 58: Traditional
Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast,
2007-2012 78
Table 59: Traditional Wound Management, Republic of Korea,
Overall Volume (Units), Historic, 2000-2007 79
Table 60: Traditional Wound
Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012
80
Table 61: Traditional Wound Management, Republic of Korea, Average
Price ($), Historic, 2000-2007 81
Table 62: Traditional Wound Management,
Republic of Korea, Average Price ($), Forecast, 2007-2012 82
Table 63:
Traditional Wound Management, Republic of Korea, Distribution Share by Revenue
($ mn), 2005-2006 83
Table 64: Traditional Wound Management, Republic of
Korea, Company Share by Revenue ($ mn), 2005-2006 84
Table 65: Compression
Therapy, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007
85
Table 66: Compression Therapy, Republic of Korea, Overall Revenues ($
mn), Forecast, 2007-2012 86
Table 67: Compression Therapy, Republic of
Korea, Overall Volume (Units), Historic, 2000-2007 87
Table 68:
Compression Therapy, Republic of Korea, Overall Volume (Units), Forecast,
2007-2012 88
Table 69: Compression Therapy, Republic of Korea, Average
Price ($), Historic, 2000-2007 89
Table 70: Compression Therapy, Republic
of Korea, Average Price ($), Forecast, 2007-2012 90
Table 71: Compression
Therapy, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006
91
Table 72: Compression Therapy, Republic of Korea, Company Share by
Revenue ($ mn), 2005-2006 92
Table 73: Covidien Ltd./Tyco Healthcare,
SWOT Analysis, 2007 100
Table 74: Covidien Ltd./Tyco Healthcare,
Financial Statements, USD Million, 2003-2007 104
Table 75: Covidien
Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007 105
Table
76: Covidien Ltd./Tyco Healthcare, Other Locations 106
Table 77:
Covidien Ltd./Tyco Healthcare, Subsidiaries 107
Table 78: 3M Company,
SWOT Analysis, 2006 119
Table 79: 3M Company, Financial Statements,
USD Million, 2002-2006 122
Table 80: 3M Company, Financial and
Operational Overview, USD Million, 2002-2006 123
Table 81: 3M
Company, Subsidiaries 124
Table 82: Ethicon, Inc., Other Locations
127
Table 83: Ethicon, Inc., Subsidiaries 128
Table 84:
Smith & Nephew Plc, SWOT Analysis, 2006 138
Table 85: Smith & Nephew
Plc, Financial Statements, USD Million, 2002-2006 141
Table 86: Smith
& Nephew Plc, Financial Ratios, USD Million, 2002-2006 142
Table 87:
Smith & Nephew Plc, Other Locations 143
Table 88: HARTMANN GROUP,
SWOT Analysis, 2006 151
Table 89: HARTMANN GROUP, Financial
Statements, Euro Thousand, 2002-2006 155
Table 90: HARTMANN GROUP,
Financial Ratios, Euro Thousand, 2002-2006 156
Table 91: HARTMANN
GROUP, Subsidiaries 157
Table 92: Classification of Medical Equipment in
Republic of Korea 158
Table 93: Currency Conversion from USD to Local
Currency at 2007 Constant Rate 170
1.2 List of Figures
Figure 1:
Healthcare Financing in Republic of Korea, 2007 18
Figure 2: Healthcare
Expenditure in Republic of Korea, 2000 - 2006 19
Figure 3: Wound Care
Management, Republic of Korea, Overall Revenues ($ mn), 2000-2012 25
Figure 4: Wound Care Management, Republic of Korea, Overall Revenues ($ mn),
Historic, 2000-2007 26
Figure 5: Wound Care Management, Republic of Korea,
Overall Revenues ($ mn), Forecast, 2007-2012 27
Figure 6: Wound Care
Management, Republic of Korea, Category Revenues ($ mn), 2000-2012 28
Figure 7: Wound Care Management, Republic of Korea, Category Revenues ($ mn),
Historic, 2000-2007 29
Figure 8: Wound Care Management, Republic of Korea,
Category Revenues ($ mn), Forecast, 2007-2012 30
Figure 9: Wound Care
Management, Republic of Korea, Category Volume (Units), 2000-2012 31
Figure 10: Wound Care Management, Republic of Korea, Category Volume (Units),
Historic, 2000-2007 32
Figure 11: Wound Care Management, Republic of
Korea, Category Volume (Units), Forecast, 2007-2012 33
Figure 12: Wound
Care Management, Republic of Korea, Company Share (%), 2006 34
Figure 13:
Wound Closure Devices, Republic of Korea, Overall Revenues ($ mn), Historic,
2000-2007 35
Figure 14: Wound Closure Devices, Republic of Korea, Overall
Revenues ($ mn), Forecast, 2007-2012 36
Figure 15: Wound Closure Devices,
Republic of Korea, Revenue by Segment ($ mn), Historic, 2000-2007 37
Figure 16: Wound Closure Devices, Republic of Korea, Revenue by Segment ($
mn), Forecast, 2007-2012 38
Figure 17: Skin Closure Devices, Republic of
Korea, Overall Revenues ($ mn), Historic, 2000-2007 39
Figure 18: Skin
Closure Devices, Republic of Korea, Overall Revenues ($ mn), Forecast,
2007-2012 40
Figure 19: Hemostats, Republic of Korea, Overall Revenues ($
mn), Historic, 2000-2007 41
Figure 20: Hemostats, Republic of Korea,
Overall Revenues ($ mn), Forecast, 2007-2012 42
Figure 21: Tissue
Sealants, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007
43
Figure 22: Tissue Sealants, Republic of Korea, Overall Revenues ($ mn),
Forecast, 2007-2012 44
Figure 23: Wound Closure Devices, Republic of
Korea, Overall Volume (Units), Historic, 2000-2007 45
Figure 24: Wound
Closure Devices, Republic of Korea, Overall Volume (Units), Forecast,
2007-2012 46
Figure 25: Skin Closure Devices, Republic of Korea, Overall
Volume (Units), Historic, 2000-2007 47
Figure 26: Skin Closure Devices,
Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 48
Figure
27: Hemostats, Republic of Korea, Overall Volume (Units), Historic, 2000-2007
49
Figure 28: Hemostats, Republic of Korea, Overall Volume (Units),
Forecast, 2007-2012 50
Figure 29: Tissue Sealants, Republic of Korea,
Overall Volume (Units), Historic, 2000-2007 51
Figure 30: Tissue Sealants,
Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 52
Figure
31: Hemostats, Republic of Korea, Average Price ($), Historic, 2000-2007
53
Figure 32: Hemostats, Republic of Korea, Average Price ($), Forecast,
2007-2012 54
Figure 33: Tissue Sealants, Republic of Korea, Average Price
($), Historic, 2000-2007 55
Figure 34: Tissue Sealants, Republic of Korea,
Average Price ($), Forecast, 2007-2012 56
Figure 35: Skin Closure Devices,
Republic of Korea, Average Price ($), Historic, 2000-2007 57
Figure 36:
Skin Closure Devices, Republic of Korea, Average Price ($), Forecast,
2007-2012 58
Figure 37: Wound Closure Devices, Republic of Korea,
Distribution Share (%), 2006 59
Figure 38: Wound Closure Devices, Republic
of Korea, Company Share (%), 2006 60
Figure 39: Ostomy, Republic of Korea,
Overall Revenues ($ mn), Historic, 2000-2007 61
Figure 40: Ostomy,
Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 62
Figure
41: Ostomy, Republic of Korea, Overall Volume (Units), Historic, 2000-2007
63
Figure 42: Ostomy, Republic of Korea, Overall Volume (Units), Forecast,
2007-2012 64
Figure 43: Ostomy, Republic of Korea, Average Price ($),
Historic, 2000-2007 65
Figure 44: Ostomy, Republic of Korea, Average Price
($), Forecast, 2007-2012 66
Figure 45: Ostomy, Republic of Korea, Company
Share (%), 2006 68
Figure 46: Advanced Wound Management, Republic of
Korea, Overall Revenues ($ mn), Historic, 2000-2007 69
Figure 47: Advanced
Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast,
2007-2012 70
Figure 48: Advanced Wound Management, Republic of Korea,
Overall Volume (Units), Historic, 2000-2007 71
Figure 49: Advanced Wound
Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012
72
Figure 50: Advanced Wound Management, Republic of Korea, Average Price
($), Historic, 2000-2007 73
Figure 51: Advanced Wound Management, Republic
of Korea, Average Price ($), Forecast, 2007-2012 74
Figure 52: Advanced
Wound Management, Republic of Korea, Distribution Share (%), 2006 75
Figure 53: Advanced Wound Management, Republic of Korea, Company Share (%),
2006 76
Figure 54: Traditional Wound Management, Republic of Korea,
Overall Revenues ($ mn), Historic, 2000-2007 77
Figure 55: Traditional
Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast,
2007-2012 78
Figure 56: Traditional Wound Management, Republic of Korea,
Overall Volume (Units), Historic, 2000-2007 79
Figure 57: Traditional
Wound Management, Republic of Korea, Overall Volume (Units), Forecast,
2007-2012 80
Figure 58: Traditional Wound Management, Republic of Korea,
Average Price ($), Historic, 2000-2007 81
Figure 59: Traditional Wound
Management, Republic of Korea, Average Price ($), Forecast, 2007-2012 82
Figure 60: Traditional Wound Management, Republic of Korea, Distribution Share
(%), 2006 83
Figure 61: Traditional Wound Management, Republic of Korea,
Company Share (%), 2006 84
Figure 62: Compression Therapy, Republic of
Korea, Overall Revenues ($ mn), Historic, 2000-2007 85
Figure 63:
Compression Therapy, Republic of Korea, Overall Revenues ($ mn), Forecast,
2007-2012 86
Figure 64: Compression Therapy, Republic of Korea, Overall
Volume (Units), Historic, 2000-2007 87
Figure 65: Compression Therapy,
Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 88
Figure
66: Compression Therapy, Republic of Korea, Average Price ($), Historic,
2000-2007 89
Figure 67: Compression Therapy, Republic of Korea, Average
Price ($), Forecast, 2007-2012 90
Figure 68: Compression Therapy, Republic
of Korea, Distribution Share (%), 2006 91
Figure 69: Compression Therapy,
Republic of Korea, Company Share (%), 2006 92
Figure 70: Covidien
Ltd./Tyco Healthcare, Value Chain Analysis 98
Figure 71: 3M Company,
Value Chain Analysis 117
Figure 72: Smith & Nephew Plc, Value Chain
Analysis 136
Figure 73: HARTMANN GROUP, Value Chain Analysis 150
Figure 74: Evaluation (Value Appraisal) Criteria for Medical Device
Reimbursement in Republic of Korea, 2007 163
Figure 75: Medical Device
Pricing System in Republic of Korea, 2007 164
Figure 76: Global Markets
Direct Methodology 166
View Cart
